CPX-351 clinical trials

Study of Standard Intensive Chemotherapy Versus Intensive Chemotherapy With CPX-351 in Adult Patients With Newly Diagnosed AML and Intermediate- or Adverse Genetics

This study is looking at a new combination of medicines (CPX-351) compared to standard treatment for adults newly diagnosed with a type of blood cancer called Acute Myeloid Leukemia (AML). We want to see if the new combination helps people live longer.